COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …

Pulmonary embolism (PE) is a life-threatening complication arising from venous
thromboembolism with a difficult diagnosis and treatment and is often associated with …

Coronavirus disease 2019 (COVID-19) does not only affect the respiratory system but
appears to be a systemic disease. Venous thromboembolism is a common manifestation in …

A COVID-19–positive patient presented with pleuritic chest pain and cough and was found
to have acute pulmonary embolisms (APEs). There has been an increase in observational …

Purpose To detect the risk factors for pulmonary embolism (PE) in patients with COVID-19.
Methods Studies were searched for in PubMed, Cochrane Library, Web of Science, and …

Although COVID-19 was primarily considered a respiratory illness, rapidly accumulating
data suggest that COVID-19 is associated with a high incidence of venous thromboembolic …

The high incidence of thromboembolic disease, and in particular venous thromboembolism
(VTE), has emerged as an important consideration in hospitalized and critically ill patients …

The clinical course of coronavirus disease 2019 (COVID-19) is often complicated by the
onset of venous thrombosis and thromboembolism (VTE), encompassing also pulmonary …

Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …

Background Acute pulmonary embolism (PE) has been described as a frequent and
prognostically relevant complication of COVID-19 infection. Aim We performed a systematic …